Literature DB >> 9153499

Efficacy of pyridoxal phosphate in treating an adult with intractable status epilepticus.

E Nakagawa1, T Tanaka, M Ohno, T Yamano, M Shimada.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9153499     DOI： 10.1212/wnl.48.5.1468

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  6 in total

1.  Molecular basis of reduced pyridoxine 5'-phosphate oxidase catalytic activity in neonatal epileptic encephalopathy disorder.

Authors:  Faik N Musayev; Martino L Di Salvo; Mario A Saavedra; Roberto Contestabile; Mohini S Ghatge; Alexina Haynes; Verne Schirch; Martin K Safo
Journal:  J Biol Chem       Date:  2009-09-15       Impact factor: 5.157

2.  Status Epilepticus.

Authors:  Elizabeth J. Waterhouse
Journal:  Curr Treat Options Neurol       Date:  2002-07       Impact factor: 3.598

3.  Pyridoxal phosphate is better than pyridoxine for controlling idiopathic intractable epilepsy.

Authors:  H-S Wang; M-F Kuo; M-L Chou; P-C Hung; K-L Lin; M-Y Hsieh; M-Y Chang
Journal:  Arch Dis Child       Date:  2005-05       Impact factor: 3.791

Review 4.  Recent advances in amino acid and organic acid metabolism.

Authors:  J V Leonard
Journal:  J Inherit Metab Dis       Date:  2007-01-19       Impact factor: 4.750

Review 5.  A review of traditional and novel treatments for seizures in autism spectrum disorder: findings from a systematic review and expert panel.

Authors:  Richard E Frye; Daniel Rossignol; Manuel F Casanova; Gregory L Brown; Victoria Martin; Stephen Edelson; Robert Coben; Jeffrey Lewine; John C Slattery; Chrystal Lau; Paul Hardy; S Hossein Fatemi; Timothy D Folsom; Derrick Macfabe; James B Adams
Journal:  Front Public Health       Date:  2013-09-13

Review 6.  Super-Refractory Status Epilepticus: Prognosis and Recent Advances in Management.

Authors:  Batool F Kirmani; Katherine Au; Lena Ayari; Marita John; Padmashri Shetty; Robert J Delorenzo
Journal:  Aging Dis       Date:  2021-07-01       Impact factor: 6.745
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.